Health In Tech (NASDAQ:HIT) reported quarterly losses of $(0.01) per share which met the analyst consensus estimate. The company reported quarterly sales of $7.509 million which beat the analyst consensus estimate of $7.274 million by 3.24 percent. This is a 53.09 percent increase over sales of $4.905 million the same period last year.